Sam Schulman
Impact in
- Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Venous Thromboembolism Diagnosis and Management 268
- Hematology 141
- Hemophilia Treatment and Research 67
- Blood Coagulation and Thrombosis Mechanisms 65
- Platelet Disorders and Treatments 17
- Co-authors
- Clive Kearon (42 shared papers)David Bergqvist (4 shared papers)Ulf Angerås (2 shared papers)Michael Rud Lassen (2 shared papers)Henry Eriksson (21 shared papers)Samuel Zachary Goldhaber (27 shared papers)Sebastian Schellong (25 shared papers)Ajay K. Kakkar (20 shared papers)
- Journals
- Journal of Thrombosis and Haemostasis (71 papers)Thrombosis and Haemostasis (64 papers)Blood (38 papers)Thrombosis Research (31 papers)Seminars in Thrombosis and Hemostasis (27 papers)
- Partner nations
- CanadaSwedenUnited States
In The Last Decade
Sam Schulman
505 papers receiving 43.8k citations
Sam Schulman's Hit Papers
Peers
Comparison fields: 5 of 154
- Internal Medicine 19.8k
- Cardiology and Cardiovascular Medicine 13.1k
- Hematology 6.4k
- Biochemistry 1.6k
- Critical Care and Intensive Care Medicine 923
Countries citing papers authored by Sam Schulman
This map shows the geographic impact of Sam Schulman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Schulman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Schulman more than expected).
Fields of papers citing papers by Sam Schulman
This network shows the impact of papers produced by Sam Schulman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Schulman. The network helps show where Sam Schulman may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Schulman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 532 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients Hit paper breakdown → | 2005 | 4223 |
| 2 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients Hit paper breakdown → | 2009 | 3414 |
| 3 | COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Hit paper breakdown → | 2020 | 2275 |
| 4 | Prevention of VTE in Nonsurgical Patients Hit paper breakdown → | 2012 | 2258 |
| 5 | Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Hit paper breakdown → | 2009 | 2054 |
| 6 | Prevention of VTE in Orthopedic Surgery Patients Hit paper breakdown → | 2012 | 1519 |
| 7 | 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Hit paper breakdown → | 2024 | 1394 |
| 8 | Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH Hit paper breakdown → | 2015 | 1143 |
| 9 | Evidence-Based Management of Anticoagulant Therapy Hit paper breakdown → | 2012 | 996 |
| 10 | American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism Hit paper breakdown → | 2020 | 959 |
| 11 | 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association Hit paper breakdown → | 2022 | 929 |
| 12 | Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Hit paper breakdown → | 2015 | 808 |
| 13 | Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Hit paper breakdown → | 2013 | 791 |
| 14 | Treatment and Prevention of Heparin-Induced Thrombocytopenia Hit paper breakdown → | 2012 | 769 |
| 15 | Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Hit paper breakdown → | 2013 | 757 |
| 16 | Antithrombotic Therapy for Atrial Fibrillation Hit paper breakdown → | 2012 | 754 |
| 17 | A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism Hit paper breakdown → | 1995 | 752 |
| 18 | Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Hit paper breakdown → | 2014 | 673 |
| 19 | 2008 | 569 | |
| 20 | 1996 | 521 |
About Sam Schulman
Sam Schulman is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Biochemistry and Infectious Diseases, having authored 532 papers that have together received 46.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (268 papers), Atrial Fibrillation Management and Outcomes (115 papers), Hemophilia Treatment and Research (67 papers), Blood Coagulation and Thrombosis Mechanisms (65 papers), Blood transfusion and management (22 papers), Platelet Disorders and Treatments (17 papers), COVID-19 Clinical Research Studies (15 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (10 papers). The work is most often cited by research in Internal Medicine (19.8k citations), Cardiology and Cardiovascular Medicine (13.1k citations), Hematology (6.4k citations), Biochemistry (1.6k citations) and Critical Care and Intensive Care Medicine (923 citations). Sam Schulman has collaborated with scholars based in Canada, Sweden and United States. Frequent co-authors include Clive Kearon, David Bergqvist, Ulf Angerås, Michael Rud Lassen, Henry Eriksson, Samuel Zachary Goldhaber, Sebastian Schellong, Ajay K. Kakkar, Alex C. Spyropoulos and Patrick Mismetti. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Blood, Thrombosis Research and Seminars in Thrombosis and Hemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.